A selection of recent
publications from the
Samsara team

Publications
IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms (2021) Journal for Immunotherapy of Cancer
Digesting the crisis: autophagy and coronaviruses (2020) Microbial Cell
Importance of Quantifying Drug-Target Engagement in Cells (2020) ACS Med. Chem. Lett.
A discovery platform for the identification of caloric restriction mimetics with broad health-improving effects (2020) Autophagy
Caloric Restriction Mimetics against Age-Associated Disease: Targets, Mechanisms, and Therapeutic Potential (2019) Cell Metabolism
Biological Functions of Autophagy Genes: A Disease Perspective (2019)
Yeast as a tool to identify anti-aging compounds (2018) Oxford Journals: FEMS Yeast Research
The flavonoid 4,4′-dimethoxychalcone promotes autophagy-dependent longevity across species (2018) Nature Communications
Therapeutic modulation of autophagy: Which disease comes first? (2019) Cell Death & Differentiation
The Hallmarks of Aging (2013) Cell
Samsara Therapeutics Establishes Scientific Advisory Board
Michael Schlossmacher, Susan Perlman, Ed Tate and Christian Behl to help advance development of neurodegeneration and rare genetic disease therapeutics
More additions to the Samsara Therapeutics team
We’re pleased to report that we’ve further strengthened our team in Oxford.
Neurodegeneration, lysosomal dysfunction and autophagy
There is a desperate need for novel therapies that can prevent the progressive neurodegeneration in debilitating diseases of ageing, such as Alzheimer’s, Parkinson’s and Huntington’s Disease.
New home and strengthening our scientific team
It’s a busy time for Samsara Therapeutics as we move into our new purpose-built labs and offices in the Wood Centre for Innovation in Oxford.
© 2021 Samsara Therapeutics | Legal Information | Privacy
© 2021 Samsara Therapeutics
Legal Information | Privacy